Health Care

   
      

Health Care

Commentary
Commentary
Video

Decision-Making in R&D

December 2013
BCG research published in Nature Reviews Drug Discovery does not show a correlation between company size and the likelihood of R&D success. But if size does not matter, what does?
January 2016
Despite general challenges to productivity in biopharma R&D, a few companies continue to excel. The key is their superior organizational effectiveness, which enhances cooperative behavior among R&D staff.
April 2016
Reorganization is a powerful lever for boosting company performance, but the results are often disappointing. A smart new approach dramatically increases the likelihood of success.
February 2015
R&D productivity has been declining for decades, but a record 53 new therapeutic drugs approved by the U.S. FDA in 2014 suggest that the biopharma industry's fortunes have changed.

Focus on Biopharma

April 2016
Top-line growth is an imperative for medtech and biopharma. With so much pressure to contain costs, these companies need to find new ways to thrive and grow.
July 2015
BCG has identified a new approach to help pharmaceutical companies improve the robustness of their manufacturing processes, a shift that could save the industry $25 billion.
February 2016
Biopharma companies are more focused than ever on the operational performance of clinical development. Benchmarking has identified eight factors associated with improved clinical-development performance.
June 2015
Biopharmaceutical manufacturing quality levels remain below those of other industries—making it critical for biopharma companies to up the effectiveness and efficiency of their quality efforts.
May 2015
Biologics representing billions of dollars in sales will lose their marketing exclusivity over the next few years—but the market for biosimilars will grow more slowly than expected.

Value-Based Health Care

December 2015
A new European Parliament directive aims for a procurement approach that considers patient outcomes and total costs over the life of health care purchases.

The Payer Agenda

April 2016
As large US health plans consolidate and grow bigger and more powerful, Blue Cross and Blue Shield plans need to take steps to become more competitive.
April 2016
As the health insurance market continues to defy expectations, payers must set aside failed predictions and address what's really happening in their markets.
September 2015
By facilitating better decision making, payers can lower costs by €100 million to €200 million for every million lives covered and at the same time improve patient outcomes.
July 2015
Consolidation won’t move the needle on health care value unless the newly combined insurers use some of the savings to invest in and extend their clinical capabilities.
Health Care in Emerging Markets
June 2015
A new report by the World Economic Forum, written with BCG, analyzes which aspects of the Ebola response worked well and where the effort fell short.
December 2015
Chronic child hunger is one of the world's most complex problems. Smart Simplicity can be a powerful ally in tackling it.
January 2015
The results of pilot initiatives in Africa bode well for emerging economies that are looking to create cost-effective, sustainable health systems.